The unique properties of IgG4 and its roles in health and disease

T Rispens, MG Huijbers - Nature Reviews Immunology, 2023 - nature.com
IgG4 is the least abundant subclass of IgG in human serum and has unique functional
features. IgG4 is largely unable to activate antibody-dependent immune effector responses …

IgG4-Mediated Neurologic Autoimmunities: Understanding the Pathogenicity of IgG4, Ineffectiveness of IVIg, and Long-Lasting Benefits of Anti–B Cell Therapies

MC Dalakas - Neurology: Neuroimmunology & Neuroinflammation, 2021 - AAN Enterprises
Background and Objectives Describe the unique functions of immunoglobulin G4 (IgG4) in
IgG4-neurologic disorders (IgG4-ND) and explain why, in contrast to their IgG1-counterparts …

[HTML][HTML] Therapeutic monoclonal antibody therapies in chronic autoimmune demyelinating neuropathies

C Briani, A Visentin - Neurotherapeutics, 2022 - Elsevier
Autoimmune diseases of the peripheral nervous system have so far been treated mainly with
exogenous high-dose intravenous immunoglobulins (IVIg), that act through several …

Anti-pan-neurofascin antibodies induce subclass-related complement activation and nodo-paranodal damage

L Appeltshauser, H Junghof, J Messinger, J Linke… - Brain, 2023 - academic.oup.com
Autoimmune neuropathy associated with antibodies against pan-neurofascin is a new
subtype of nodo-paranodopathy. It is relevant because it is associated with high morbidity …

Telitacicept: A novel horizon in targeting autoimmunity and rheumatic diseases

L Zeng, K Yang, Y Wu, G Yu, Y Yan, M Hao… - Journal of …, 2024 - Elsevier
BLyS and APRIL have the capability to bind to B cells within the body, allowing these cells to
evade elimination when they should naturally be removed. While BLyS primarily plays a role …

Autoimmune nodopathies, an emerging diagnostic category

L Martín-Aguilar, C Lleixà… - Current Opinion in …, 2022 - journals.lww.com
AN have emerged as a new diagnostic category pathologically different from acquired
demyelinating neuropathies. Clinically they overlap with GBS and CIDP although they …

IgG4 autoantibodies in organ-specific autoimmunopathies: reviewing class switching, antibody-producing cells, and specific immunotherapies

I Koneczny, J Tzartos, M Mané-Damas… - Frontiers in …, 2022 - frontiersin.org
Organ-specific autoimmunity is often characterized by autoantibodies targeting proteins
expressed in the affected tissue. A subgroup of autoimmunopathies has recently emerged …

Autoimmune neurological disorders with IgG4 antibodies: a distinct disease spectrum with unique IgG4 functions responding to anti-B cell therapies

MC Dalakas - Neurotherapeutics, 2022 - Springer
The main IgG4 antibody–mediated neurological disorders (IgG4-ND) include MuSK
myasthenia; CIDP with nodal/paranodal antibodies to Neurofascin-155, contactin-1/caspr-1 …

Growing spectrum of autoimmune nodopathies

P Gupta, I Mirman, S Shahar, D Dubey - Current neurology and …, 2023 - Springer
Abstract Purpose of Review Recognition of node of Ranvier as the site of injury in
inflammatory neuropathies contributed to discovery of antibodies against the …

IgG4 valency modulates the pathogenicity of anti–neurofascin-155 igG4 in autoimmune nodopathy

A Jentzer, A Attal, C Roué, J Raymond… - Neurology …, 2022 - AAN Enterprises
Background and Objectives IgG4 autoantibodies to neurofascin-155 (Nfasc155) are
associated with a subgroup of patients with chronic inflammatory demyelinating …